Bioanalytical Systems Company Profile (NASDAQ:BASI)

About Bioanalytical Systems (NASDAQ:BASI)

Bioanalytical Systems logoBioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NASDAQ:BASI
  • CUSIP: N/A
  • Web: www.basinc.com
Capitalization:
  • Market Cap: $14.99 million
  • Outstanding Shares: 8,238,000
Average Prices:
  • 50 Day Moving Avg: $1.70
  • 200 Day Moving Avg: $1.62
  • 52 Week Range: $0.60 - $2.42
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 22.75
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $23.52 million
  • Price / Sales: 0.64
  • Book Value: $0.87 per share
  • Price / Book: 2.09
Profitability:
  • EBITDA: $1.65 million
  • Net Margins: -5.88%
  • Return on Equity: -20.72%
  • Return on Assets: -6.61%
Debt:
  • Debt-to-Equity Ratio: 0.60%
  • Current Ratio: 0.64%
  • Quick Ratio: 0.51%
Misc:
  • Average Volume: 34,186 shs.
  • Beta: 1.35
  • Short Ratio: 0.25
 

Frequently Asked Questions for Bioanalytical Systems (NASDAQ:BASI)

What is Bioanalytical Systems' stock symbol?

Bioanalytical Systems trades on the NASDAQ under the ticker symbol "BASI."

How were Bioanalytical Systems' earnings last quarter?

Bioanalytical Systems, Inc. (NASDAQ:BASI) issued its quarterly earnings data on Monday, August, 14th. The company reported $0.03 EPS for the quarter. The company earned $5.84 million during the quarter. Bioanalytical Systems had a negative net margin of 5.88% and a negative return on equity of 20.72%. View Bioanalytical Systems' Earnings History.

When will Bioanalytical Systems make its next earnings announcement?

Bioanalytical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, December, 20th 2017. View Earnings Estimates for Bioanalytical Systems.

Who are some of Bioanalytical Systems' key competitors?

Who are Bioanalytical Systems' key executives?

Bioanalytical Systems' management team includes the folowing people:

  • Gregory C. Davis Ph.D., Interim Chairman of the Board
  • Jill Blumhoff, Chief Financial Officer, Vice President - Finance
  • James S. Bourdage Ph.D., Vice President - Bioanalytical Operations
  • Philip A. Downing, Vice President - Preclinical Services
  • Connie Dougherty, Vice President - Business Development
  • Richard Allen Johnson Ph.D., Independent Director
  • R. Matthew Neff, Independent Director
  • Wendy Perrow, Independent Director

How do I buy Bioanalytical Systems stock?

Shares of Bioanalytical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bioanalytical Systems' stock price today?

One share of Bioanalytical Systems stock can currently be purchased for approximately $1.82.


MarketBeat Community Rating for Bioanalytical Systems (NASDAQ BASI)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about Bioanalytical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bioanalytical Systems (NASDAQ:BASI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Bioanalytical Systems (NASDAQ:BASI)
Price Target History for Bioanalytical Systems (NASDAQ:BASI)
Analysts' Ratings History for Bioanalytical Systems (NASDAQ:BASI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Bioanalytical Systems (NASDAQ:BASI)
Earnings by Quarter for Bioanalytical Systems (NASDAQ:BASI)
Earnings History by Quarter for Bioanalytical Systems (NASDAQ BASI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/20/2017N/AView Earnings Details
8/14/2017Q3 2017$0.03$5.84 millionViewN/AView Earnings Details
5/15/2017Q2 2017$0.05$6.36 millionViewN/AView Earnings Details
8/11/2016Q316($0.05)$6.15 million$5.05 millionViewListenView Earnings Details
5/12/2016Q216($0.03)$5.73 million$5.34 millionViewListenView Earnings Details
2/16/2016Q116($0.06)$5.95 million$4.90 millionViewListenView Earnings Details
12/17/2015Q415($0.09)$6.42 million$4.98 millionViewListenView Earnings Details
8/13/2015Q315$0.16$6.03 million$6.15 millionViewListenView Earnings Details
5/14/2015Q215($0.01)$5.92 million$5.73 millionViewListenView Earnings Details
2/12/2015Q115$0.01$6.22 million$5.85 millionViewN/AView Earnings Details
12/22/2014Q414($0.02)$6.42 millionViewN/AView Earnings Details
8/14/2014Q314$0.02$5.60 million$6.03 millionViewN/AView Earnings Details
5/15/2014Q2($0.03)$5.16 million$5.91 millionViewListenView Earnings Details
2/13/2014Q114$0.04$5.80 million$6.22 millionViewN/AView Earnings Details
12/24/2013Q4 13$0.03$6.54 million$5.51 millionViewN/AView Earnings Details
10/18/2013Q313$0.01$0.07$5.65 million$5.60 millionViewN/AView Earnings Details
5/15/2013Q2 2013$0.01($0.02)$5.74 million$5.16 millionViewListenView Earnings Details
2/14/2013Q1 2013($0.03)$0.02$6.65 million$5.80 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bioanalytical Systems (NASDAQ:BASI)
Current Year EPS Consensus Estimate: $0.01 EPS
Next Year EPS Consensus Estimate: $0.08 EPS

Dividends

Dividend History for Bioanalytical Systems (NASDAQ:BASI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Bioanalytical Systems (NASDAQ:BASI)
Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 4.06%
Insider Trades by Quarter for Bioanalytical Systems (NASDAQ:BASI)
Insider Trades by Quarter for Bioanalytical Systems (NASDAQ:BASI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/8/2017R Matthew NeffDirectorBuy5,000$1.50$7,500.00View SEC Filing  
8/18/2017R Matthew NeffDirectorBuy5,000$1.70$8,500.00View SEC Filing  
5/27/2016Connie Leigh DoughertyVPBuy423$0.92$389.16View SEC Filing  
5/23/2016Connie Leigh DoughertyVPBuy96$0.92$88.32View SEC Filing  
5/19/2016Connie Leigh DoughertyVPBuy1,655$0.92$1,522.60View SEC Filing  
2/29/2016Jacqueline M LemkeCEOBuy10,000$1.18$11,800.00View SEC Filing  
9/14/2015Philip A DowningVPBuy3,000$1.73$5,190.00View SEC Filing  
2/27/2015Jacqueline M LemkeCEOBuy10,000$2.04$20,400.00View SEC Filing  
6/13/2014John P DevineVPSell3,130$2.64$8,263.20View SEC Filing  
8/17/2012David L OmachinskiDirectorBuy10,000$1.26$12,600.00View SEC Filing  
8/17/2012Jacqueline M LemkeCEOBuy20,000$1.26$25,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Bioanalytical Systems (NASDAQ:BASI)
Latest Headlines for Bioanalytical Systems (NASDAQ:BASI)
Source:
DateHeadline
finance.yahoo.com logoGaining Momentum: BASi Adds Candace Rohde-Johnson as Director of in Vivo Products and Services
finance.yahoo.com - October 3 at 4:06 PM
finance.yahoo.com logoBioanalytical Systems Inc (BASI): Is Healthcare An Attractive Sector Play?
finance.yahoo.com - September 22 at 3:18 PM
finance.yahoo.com logoBASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
finance.yahoo.com - September 6 at 4:15 PM
finance.yahoo.com logoFeatured Company News - Myriad Genetics' EndoPredict Receives Positive Coverage Decisions from Palmetto and Anthem
finance.yahoo.com - August 22 at 10:03 PM
finance.yahoo.com logoBioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:58 PM
finance.yahoo.com logoBioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:58 PM
americanbankingnews.com logoBioanalytical Systems, Inc. (BASI) Releases Earnings Results
www.americanbankingnews.com - August 15 at 9:41 AM
finance.yahoo.com logoBASi Reports Continued Profitability Improvement in Third Quarter
finance.yahoo.com - August 14 at 4:44 PM
finance.yahoo.com logoBASi Announces Election of R. Matthew Neff to the Board of Directors
finance.yahoo.com - August 3 at 5:46 PM
americanbankingnews.com logoBioanalytical Systems, Inc. (NASDAQ:BASI) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - August 2 at 7:20 AM
finance.yahoo.com logoBASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex(R) Automated Blood Sampling Systems
finance.yahoo.com - July 31 at 4:27 PM
finanznachrichten.de logoBioanalytical Systems, Inc.: BASi Names Dr. Gregory C. Davis to Board of Directors
www.finanznachrichten.de - June 20 at 4:31 PM
reuters.com logoBRIEF-BASI reports Q2 earnings per share $0.05
www.reuters.com - May 17 at 12:06 PM
biz.yahoo.com logoQ1 2017 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - February 14 at 8:27 PM
us.rd.yahoo.com logoBASi Reports First Quarter Results
us.rd.yahoo.com - February 14 at 8:27 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
biz.yahoo.com - January 17 at 4:32 PM
biz.yahoo.com logoQ4 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - December 22 at 3:51 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
biz.yahoo.com - December 22 at 3:51 PM
biz.yahoo.com logoBioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM
biz.yahoo.com logoBioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
biz.yahoo.com - December 7 at 4:26 PM
reuters.com logoBRIEF-Basi Q3 loss per share $0.05
www.reuters.com - August 12 at 12:20 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure
biz.yahoo.com - August 4 at 3:50 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
biz.yahoo.com - July 22 at 3:12 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM
biz.yahoo.com logoQ2 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
biz.yahoo.com - May 12 at 7:07 AM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
biz.yahoo.com - May 4 at 1:16 PM
biz.yahoo.com logoBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 16 at 3:52 PM

Social

Chart

Bioanalytical Systems (BASI) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.